IMMUNE RESPONSE TO COVID-19 COMPARED TO THE IMMUNE RESPONSE TO SARS, MERS AND INFLUENZA

IMMUNE RESPONSE TO COVID-19 COMPARED TO THE IMMUNE RESPONSE TO SARS, MERS AND INFLUENZA

The course, form and outcome of an acute respiratory illness, as well as its patho-histological features largely depend on the level of inflammatory cytokines. The most important proinflammatory cytokines and chemokines are: IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-17A, IFN-γ, TNF-α a...

Szczegółowa specyfikacja

Opis bibliograficzny
1. autor:	Velo Markovski
Format:	Artykuł
Język:	English
Wydane:	National Center of Infectious and Parasitic Diseases 2020-10-01
Seria:	Problems of Infectious and Parasitic Diseases
Hasła przedmiotowe:	immune response COVID-19 SARS MERS Influenza
Dostęp online:	https://pipd.ncipd.org/index.php/pipd/article/view/26

Podobne zapisy

Immune Status of COVID-19 Patients with Reference to SARS and MERS
od: Barani Karikalan, i wsp.
Wydane: (2020-05-01)

Immune Response to COVID-19: Can We Benefit from the SARS-CoV and MERS-CoV Pandemic Experience?
od: Emilia Sinderewicz, i wsp.
Wydane: (2020-09-01)

Immune Profiling of COVID-19 in Correlation with SARS and MERS
od: Bariaa A. Khalil, i wsp.
Wydane: (2022-01-01)

Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
od: Yanwen Liang, i wsp.
Wydane: (2020-05-01)

A Comparative Analysis on SARS, MERS and COVID-19
od: Atiksh Chandra, i wsp.
Wydane: (2020-09-01)

SARS, MERS and COVID-19 among healthcare workers: A narrative review
od: Jian Xiao, i wsp.
Wydane: (2020-06-01)

Comparative Study of SARS-CoV-2, SARS-CoV-1, MERS-CoV, HCoV-229E and Influenza Host Gene Expression in Asthma: Importance of Sex, Disease Severity, and Epithelial Heterogeneity
od: Mackenzie E. Coden, i wsp.
Wydane: (2021-06-01)

Drawing parallels between SARS, MERS, and COVID-19: A comparative overview of epidemiology, pathogenesis, and pathological features
od: Manas Pustake, i wsp.
Wydane: (2023-01-01)

Meta-analysis and comprehensive study of coronavirus outbreaks: SARS, MERS and COVID-19
od: Engin Berber, i wsp.
Wydane: (2021-08-01)

Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2
od: Xue-Yan Zhang, i wsp.
Wydane: (2020-07-01)

Coronavirus-associated kidney outcomes in COVID-19, SARS, and MERS: a meta-analysis and systematic review
od: Shoulian Zhou, i wsp.
Wydane: (2021-01-01)

Evaluating the Immune Response in Treatment-Naive Hospitalised Patients With Influenza and COVID-19
od: Jelmer Legebeke, i wsp.
Wydane: (2022-05-01)

Structure and functions of Mer, an innate immune checkpoint
od: Eric Ubil, i wsp.
Wydane: (2023-10-01)

Periodic oscillation for a class of in-host MERS-CoV infection model with CTL immune response
od: Tuersunjiang Keyoumu, i wsp.
Wydane: (2022-08-01)

Effects of Influenza Vaccine on the Immune Responses to SARS-CoV-2 Vaccination
od: A. Riccomi, i wsp.
Wydane: (2024-04-01)

Role of the cellular immunity in the formation of the immune response in coronavirus infections
od: I. A. Ivanova, i wsp.
Wydane: (2021-12-01)

SARS, MERS and COVID-19-Associated Renal Pathology
od: Hristo Popov, i wsp.
Wydane: (2022-10-01)

A comparison of COVID-19, SARS and MERS
od: Tingting Hu, i wsp.
Wydane: (2020-08-01)

Characterization of the Immune Response of MERS-CoV Vaccine Candidates Derived from Two Different Vectors in Mice
od: Entao Li, i wsp.
Wydane: (2020-01-01)

Host Protective Immune Responses against Influenza A Virus Infection
od: Hi Eun Jung, i wsp.
Wydane: (2020-05-01)

Contrasting roles of MERS-CoV and SARS-CoV-2 internal proteins in pathogenesis in mice
od: Lok-Yin Roy Wong, i wsp.
Wydane: (2023-12-01)

Mortality rate of acute kidney injury in SARS, MERS, and COVID-19 infection: a systematic review and meta-analysis
od: Yih-Ting Chen, i wsp.
Wydane: (2020-07-01)

Mechanisms of Immune Dysregulation in COVID-19 Are Different From SARS and MERS: A Perspective in Context of Kawasaki Disease and MIS-C
od: Manpreet Dhaliwal, i wsp.
Wydane: (2022-05-01)

Immune response to influenza vaccination in children with cancer
od: Dimitrios Doganis, i wsp.
Wydane: (2018-09-01)

SYSTEMIC ANTIBODY AND CELLULAR IMMUNE RESPONSES IN INFLUENZA INFECTION AND POSTSVACCINATION
od: S. A. Donina, i wsp.
Wydane: (2014-07-01)

Liposome-Mediated Delivery of MERS Antigen Induces Potent Humoral and Cell-Mediated Immune Response in Mice
od: Masood Alam Khan, i wsp.
Wydane: (2022-01-01)

Influenza: Toward understanding the immune response in the young
od: Sonia Sakleshpur, i wsp.
Wydane: (2022-08-01)

Global Stability of a MERS-CoV Infection Model with CTL Immune Response and Intracellular Delay
od: Tuersunjiang Keyoumu, i wsp.
Wydane: (2023-02-01)

Response Modifiers: Tweaking the Immune Response Against Influenza A Virus
od: Husni Elbahesh, i wsp.
Wydane: (2019-04-01)

Convalescent Plasma Therapy for COVID-19: Lessons from SARS-CoV, MERS-CoV, and H1N1 Infection
od: Parastoo Hosseini, i wsp.
Wydane: (2021-03-01)

Convalescent plasma therapy for coronavirus infection: experience from MERS and application in COVID-19
od: Jaffar A. Al-Tawfiq, i wsp.
Wydane: (2020-12-01)

LOCAL ANTIBODY AND CELLULAR IMMUNE RESPONSES TO INFLUENZA INFECTION AND VACCINATION
od: G. D. Petukhova, i wsp.
Wydane: (2014-07-01)

Ethnological aspects of COVID-19
od: Priya Dhiman, i wsp.
Wydane: (2022-12-01)

Encapsulation of MERS antigen into α-GalCer-bearing-liposomes elicits stronger effector and memory immune responses in immunocompetent and leukopenic mice
od: Masood Alam Khan, i wsp.
Wydane: (2022-07-01)

A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV
od: Huan Zhou, i wsp.
Wydane: (2021-12-01)

Alterations in the Plasma Proteome Induced by SARS-CoV-2 and MERS-CoV Reveal Biomarkers for Disease Outcomes for COVID-19 Patients
od: Alaiya A, i wsp.
Wydane: (2021-09-01)

Factors affecting immune responses to the influenza vaccine
od: Maria R. Castrucci
Wydane: (2018-03-01)

Coronavirus Disease 2019 (COVID-19) in Kenya: Preparedness, response and transmissibility
od: Martin A. Aluga
Wydane: (2020-10-01)

The cellular and humoral immune response to influenza vaccination is comparable in asthmatic and healthy subjects
od: Andrea Aida Velasco-Medina, i wsp.
Wydane: (2021-01-01)

Cell-Mediated Proteomics, and Serological and Mucosal Humoral Immune Responses after Seasonal Influenza Immunization: Characterization of Serological Responders and Non-Responders
od: Hanna Carlsson, i wsp.
Wydane: (2024-03-01)